简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-02-04 12:56 Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of DFP-14323
2024-02-02 14:36 Galderma Celebrates 25 Years of Excellence in Biostimulation With Sculptra® at the 2024 IMCAS
2024-02-02 13:51 Takeda Announces Chief Financial Officer Succession
2024-02-02 13:44 Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products
2024-02-01 16:55 Tsuno Group successfully developed and applied for a patent for a stable formulation with a high dosage of FERULIC ACID, a rare natural plant-derived ingredient having the function of absorbing UV.
2024-02-01 12:18 DEKA Plays Its Poker Quad With Four New Laser Platforms at IMCAS Paris, the World Dermatology and Plastic and Aesthetic Surgery Congress
2024-01-31 16:14 Quanta System unveils the latest breakthrough technology drawn on its picosecond laser heritage: VarioPulse Technology®, the next-level device for the next-level experts
2024-01-31 13:00 Checkerspot Announces Breakthrough with the Development of Human Milk Fat Analogue by Fermentation of Microalgae
2024-01-31 12:27 PQE Group: 100+M€ in Revenues
2024-01-31 11:01 Takeda’s HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2024-01-30 11:29 2024 Japan Prize: Three Scientists from US and UK have been awarded
2024-01-30 09:54 Takeda’s GAMMAGARD LIQUID® Approved by U.S. FDA for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2024-01-29 11:51 New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics' PERLE Breast Implant
2024-01-26 11:50 Kenvue Declares Quarterly Cash Dividend
2024-01-25 14:14 IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position
2024-01-25 12:43 ReLive Biotechnologies Announces NDA Approval of SpheChon 10-70 spheroids/cm² by the HSA in Singapore, Marking a Milestone in ReLive’s Global Endeavors
2024-01-25 11:23 HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data
2024-01-24 15:23 Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
2024-01-24 15:17 Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
2024-01-24 14:14 BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors

Business Wire Weibo

Press Releases

Latest Releases